CYP2C19 pharmacogenetics in the clinical use of proton-pump inhibitors for gastro-esophageal reflux disease: variant alleles predict gastric acid suppression, but not esophageal acid exposure or reflux symptoms

Laurence J Egan

CYP2C19 pharmacogenetics in the clinical use of proton-pump inhibitors for gastro-esophageal reflux disease: variant alleles predict gastric acid suppression, but not esophageal acid exposure or reflux symptoms

Laurence J Egan

Pharmacology

Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review

Original language	English (Ireland)
Journal	Alimentary Pharmacology & Therapeutics
Volume	172
Issue number	12
Publication status	Published - 1 Jan 2003

Authors (Note for portal: view the doc link for the full list of authors)

Authors
Egan, L. J., Myhre, G. M., Mays, D. C., Dierkhising, R. A., Kammer, P. P. & Murray, J. A.

Cite this

@article{ae5d72109a5c4b72b0ecf506bd931385,

title = "CYP2C19 pharmacogenetics in the clinical use of proton-pump inhibitors for gastro-esophageal reflux disease: variant alleles predict gastric acid suppression, but not esophageal acid exposure or reflux symptoms",

author = "Egan, \{Laurence J\}",

year = "2003",

month = jan,

day = "1",

language = "English (Ireland)",

volume = "172",

journal = "Alimentary Pharmacology \& Therapeutics",

number = "12",

}

CYP2C19 pharmacogenetics in the clinical use of proton-pump inhibitors for gastro-esophageal reflux disease: variant alleles predict gastric acid suppression, but not esophageal acid exposure or reflux symptoms. / Egan, Laurence J.
In: Alimentary Pharmacology & Therapeutics, Vol. 172, No. 12, 01.01.2003.

Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review

TY - JOUR

T1 - CYP2C19 pharmacogenetics in the clinical use of proton-pump inhibitors for gastro-esophageal reflux disease: variant alleles predict gastric acid suppression, but not esophageal acid exposure or reflux symptoms

AU - Egan, Laurence J

PY - 2003/1/1

Y1 - 2003/1/1

M3 - Article

VL - 172

JO - Alimentary Pharmacology & Therapeutics

JF - Alimentary Pharmacology & Therapeutics

IS - 12

ER -